Maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 1, 2017, Pages

  Grev, Jacquelyn ^a   Berg, Marie ^a   Soll, Roger ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ARTICLE; HIGH RISK PREGNANCY; HUMAN; MATERNAL TREATMENT; MORTALITY RISK; NEWBORN MORBIDITY; NEWBORN MORTALITY; POSTNATAL CARE; PREGNANT WOMAN; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SUPPLEMENTATION; SYSTEMATIC REVIEW;

EID: 85011096692     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD012519     Document Type: Article

References (44)

1. Abrahamsson TR, Sinkiewicz G, Jakobsson T, Fredrikson M, Bjorksten B. Probiotic lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life. Journal of Pediatric Gastroenterology and Nutrition 2009;49(3):349-54. [PUBMED: 19525871]
2. Agostoni C, Buonocore G, Carnielli VP, De Curtis M, Darmaun D, Decsi T, Domellöf M, Embleton ND, Fusch C, Genzel-Boroviczeny O, Goulet O, Kalhan SC, Kolacek S, Koletzko B, Lapillonne A, Mihatsch W, Moreno L, Neu J, Poindexter B, Puntis J, Putet G, Rigo J, Riskin A, Salle B, Sauer P, Shamir R, Szajewska H, Thureen P, Turck D, van Goudoever JB, EE. Ziegler. for the ESPGHAN Committee on Nutrition. Enteral Nutrient Supply for Preterm Infants: CommentaryFrom the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition Committee on Nutrition. Journal of Pediatric Gastroenterology and Nutrition 2010;50(1):85-91.
3. Agency for Healthcare Research and Quality. Safety of Probiotics to Reduce Risk and Prevent or Treat Disease Exectuive Summary. AHRQ Publication April 2011, issue 11-E007-1.
4. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database of Systematic Reviews 2014, Issue 4. [DOI: 10.1002/14651858.CD005496.pub4]
5. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Annals of Surgery 1978;187(1):1-7. [PUBMED: 413500]
6. Bergmann H, Rodriguez JM, Salminen S, Szajewska H. Probiotics in human milk and probiotic supplementation in infant nutrition: a workshop report. British Journal of Nutrition 2014;112(7):1119-28. [PUBMED: 25160058]
7. Bertelli C, Pillonel T, Torregrossa A, Prod'hom G, Fischer CJ, Greub G, et al. Bifidobacterium longum Bacteremia in Preterm Infants Receiving Probiotics. Clinical Infectious Diseases 2015;60(6):924-7.
8. Cilieborg MS, Boye M, Sangild PT. Bacterial colonization and gut development in preterm neonates. Early Human Development 2012;88(Suppl 1):S41-9. [PUBMED: 22284985]
9. Costeloe K, Hardy P, Juszczak E, Wilks M, Millar MW, Probiotics in Preterm Infants Study Collaborative Group. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet 2016;387(10019):649-60.
10. Deshpande G, Rao S, Patole S, Bulsara M. Updated Meta-analysis of Probiotics for PreventingNecrotizing Enterocolitis in Preterm Neonates. Pediatrics 2010;125(5):921-30.
11. Dugoua JJ, Machado M, Zhu X, Chen X, Koren G, Einarson TR. Probiotic safety in pregnancy: a systematic review and meta-analysis of randomized controlled trials of Lactobacillus, Bifidobacterium, and Saccharomyces spp. Journal of Obstetrics and Gynaecology Canada 2009;31(6):542-52. [PUBMED: 19646321]
12. Elias J, Bozzo P, Einarson A. Are probiotics safe for use during pregnancy and lactation?. Canadian Family Physician 2011;57(3):299-301.
13. Faa G, Gerosa C, Fanni D, Nemolato S, van Eyken P, Fanos V. Factors influencing the development of a personal tailored microbiotain the neonate, with particular emphasis on antibiotic therapy. Journal of Maternal-Fetal & Neonatal Medicine 2013;26(Suppl 2):35-43. [PUBMED: 24059551]
14. U.S. Food, Drug Administration. Dietary Supplements Containing Live Bacteria or Yeast in Immunocompromised Persons: Warning - Risk of Invasive Fungal Disease. www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm426331.htm 12/9/2014.
15. Garland SM. A Cautionary Note on Instituting Probiotics Into Routine Clinical Care for Premature Infants. Pediatrics 2010;126(3):e741.
16. Gomez Arango LF, Barrett HL, Callaway LK, Nitert MD. Probiotics and Pregnancy. Current Diabetes Reports 2015;15(1):567. [PUBMED: 25398206]
17. McMaster University. GRADEpro [www.gradepro.org]. McMaster University, 2014.
18. Gueimonde M, Sakata S, Kalliomaki M, Isolauri E, Benno Y, Salminen S. Effect of maternal consumption of lactobacillus GG on transfer and establishment of fecal bifidobacterial microbiota in neonates. Journal of Pediatric Gastroenterology and Nutrition 2006;42(2):166-70. [PUBMED: 16456409]
19. Center for Disease Control. Fatal Gastrointestinal Mucormycosis in an Infant Following Ingestion of Contaminated Dietary Supplement - Connecticut, 2014. CDC Health Alert Network; https://emergency.cdc.gov/han/; 2014 November. Report No.: CDCHAN-00373.
20. Hickey L, Jacobs SE, Garland SM, ProPrems Study Group. Probiotics in neonatology. Journal of Paediatrics and Child Health 2012;48(9):777-83.
21. Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
22. Higgins RD, Saade G, Polin RA, Grobman WA, Buhimschi IR, Watterberg K, Silver RM, TNK Raju. Evaluation and Management of Women and Newborns With a Maternal Diagnosis of Chorioamnionitis. Obstetrics & Gynecology 2016;127(3):426-36.
23. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Archives of Ophthalmology 2005;123(7):991-9. [PUBMED: 16009843]
24. Jacobs SE, Berg M, Hunt R, Tarnow-Mordi WO, Inder TE, Davis PG. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database of Systematic Reviews 2013, Issue 1. [DOI: 10.1002/14651858.CD003311.pub3]
25. Janvier A, Lantos J, Barrington K. The politics of probiotics: probiotics, necrotizing enterocolitis and the ethics of neonatal research. Acta Paediatrica 2013;102(2):116-8.
26. Johnson CL, Versalovic J. The Human Microbiome and Its Potential Importance to Pediatrics. Pediatrics 2012;129(5):950-60.
27. Jost T, Lacroix C, Braegger CP, Rochat F, Chassard C. Vertical mother-neonate transfer of maternal gut bacteria via breastfeeding. Environmental Microbiology 2014;16(9):2891-904. [PUBMED: 24033881]
28. Keski-Nisula L, Kyynarainen HR, Karkkainen U, Karhukorpi J, Heinonen S, Pekkanen J. Maternal intrapartum antibiotics and decreased vertical transmission of Lactobacillus to neonates during birth. Acta Paediatrica 2013;102(5):480-5. [PUBMED: 23398392]
29. Lahtinen SJ, Boyle RJ, Kivivuori S, Oppedisano F, Smith KR, Robins-Browne R, et al. Prenatal probiotic administration can influence Bifidobacterium microbiota development in infants at high risk of allergy. Journal of Allergy and Clinical Immunology 2009;123(2):499-501.e8.
30. Lindsay KL, Walsh CA, Brennan L, McAuliffe FM. Probiotics in pregnancy and maternal outcomes: a systematic review. Journal of Maternal-Fetal & Neonatal Medicine 2013;26(8):772-8.
31. Mackeen AD, Packard RE, Ota E, Speer L. Antibiotic regimens for postpartum endometritis. Cochrane Database of Systematic Reviews 2015, Issue 2. [DOI: 10.1002/14651858.CD001067.pub3]
32. Matamoros S, Gras-Leguen C, Le Vacon F, Potel G, de La Cochetiere MF. Development of intestinal microbiotain infants and its impact on health. Human Microbiome 2013;21(4):167-73. [PUBMED: 23332725]
33. Mihatscha WA, Braeggerb CP, Decsic T, Kolacekd S, Lanzingere H, Mayerf B, et al. Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants. Clinical Nutrition 2012;31(1):6-15.
34. Neu J, Walker A. Necrotizing Enterocolitis. New England Journal of Medicine 2011;364(3):255-64. [PUBMED: 21247316]
35. Othman M, Alfirevic Z, Neilson JP. Probiotics for preventing preterm labour. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD005941.pub2]
36. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1, 500 gm. Journal of Pediatrics 1978;92(4):529-34. [PUBMED: 305471]
37. Reid G, Bocking A. The potential for probiotics to prevent bacterial vaginosis and preterm labor. American Journal of Obstetrics and Gynecology 2003;189(4):1202-8.
38. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
39. Schünemann H, Broz˙ek J, Guyatt G, Oxman A, editors. GRADEWG GRADE handbook for grading quality of evidence and strength of recommendations. Available from www.guidelinedevelopment.org/handbook Updated October 2013.
40. Soll RF. Probiotics: Are We Ready for Routine Use?. Pediatrics 2010;125(5):1071-2.
41. The World Bank. World Bank Country and Lending Groups. The World Bank Website. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519.
42. Thomas DW, Greer FR, and Committee on Nutrition, Section on Gastroenterology, Hepatology, Nutrition Clinical Report Probiotics and Prebiotics in Pediatrics. Pediatrics 2010;126(6):1217-1231.
43. VandeVusse L, Hanson L, Safdar N. Perinatal Outcomes of Prenatal Probioticand Prebiotic Administration. Journal of Perinatal & Neonatal Nursing 2013;27(4):288-301.
44. Viswanathan S, Lau C, Akbari H, Hoyen C, Walsh MC. Survey and evidence based review of probiotics used in very low birth weight preterm infants within the United States. Journal of Perinatology 2016;36(12):1106-11.